Authors contributions Designed and conducted the study, performed data acquisition and analysis, and wrote the manuscript: Zhang W, Xue J Collected and managed data: Wang J, Ni D, Zhou W Performed data management: Wang B, Shi J Conceived and designed the study, conducted it, interpreted the data, and revised the manuscript: Wang A All the authors have read and approved the final version of this manuscript
No extreme muscle loss
Most studies are on animal models
Tri Health Family Wellness Center Losing weight can be extremely challenging, especially for individuals who are overweight or obese and plan to lose a significant amount of weight
Garg, N
Adverse Reactions/Side Effects The following serious adverse reactions are described below or elsewhere in the prescribing information: Risk of Thyroid C-cell Tumors [see Warnings and Precautions (5.1)] Acute Pancreatitis [see Warnings and Precautions (5.2)] Diabetic Retinopathy Complications [see Warnings and Precautions (5.3)] Hypoglycemia with Concomitant Use of Insulin Secretagogues or Insulin [see Warnings and Precautions (5.4)] Acute Kidney Injury Due to Volume Depletion [see Warnings and Precautions (5.5)] Severe Gastrointestinal Adverse Reactions [see Warnings and Precautions (5.6)] Hypersensitivity Reactions [see Warnings and Precautions (5.7)] Acute Gallbladder Disease [see Warnings and Precautions (5.8)] Pulmonary Aspiration During General Anesthesia or Deep Sedation [see Warnings and Precautions (5.9)] 6.1 Clinical Trials Experience Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice
